缬沙坦与阿托伐他汀联合治疗永久性房颤的临床效果观察
2015-01-31陈锦
陈锦
缬沙坦与阿托伐他汀联合治疗永久性房颤的临床效果观察
陈锦
【摘要】目的 探讨缬沙坦与阿托伐他汀联合治疗永久性房颤的效果。方法 将86例永久性房颤患者分为两组,对照组采用常规治疗,观察组采用缬沙坦联合阿托伐他汀治疗。结果 观察组治疗后hs-CRP、NT-proBNP水平改善及治疗总有效率均优于对照组,P<0.05,差异具有统计学意义。结论 缬沙坦联合阿托伐他汀治疗永久性房颤的效果良好。【关键词】缬沙坦;阿托伐他汀;永久性房颤
作者单位:810400青海省祁连县人民医院
Observation Clinical Effect of Valsartan Combine With Atorvastatin in Treatment of Permanent Atrial Fibrillation
CHEN Jin Qilian County The People's Hospital in Qinghai Province, Qilian 810400, China
[Abstract]Objective To explore the effect of valsartan combine with atorvastatin in treatment of permanent atrial fibrillation. Methods Selected 86 patients with permanent atrial fibrillation were divided into two groups, the control group used the conventional treatment, the observation group with valsartan with atorvastatin therapy. Results The observation group of patients after treatment the hs-CRP, NT-proBNP level to improve treatment of total effective rate were better than the control group, P<0.05, had difference statistically significance. Conclusion Valsartan combine therapy with atorvastatin permanent atrial fibrillation effect is remarkable.
[Key words]Valsartan, Atorvastatin, Permanent atrial fibrillation
心房纤颤简称房颤,属于心律失常疾病的一种,临床常用抗凝药物及控制心室率治疗该疾病,但效果差强人意。我院对永久性房颤患者采用缬沙坦及阿托伐他汀联合治疗,取得了显著效果,具体报道如下。
1 资料与方法
1.1临床资料
选取我院2013年1月~2015年1月收治的永久性房颤患者86例作为研究对象,患者均经由24 h动态心电图、超声心动图检查确诊,符合永久性房颤相关诊断标准,排除阵发性房颤、合并重症感染及肝肾功能障碍患者。按随机数字表法将其分为对照组与观察组。对照组43例,男23例,女20例,年龄54~71岁,平均年龄(63.2±2.4)岁,病程5个月~3年,平均病程(1.7±0.6)年;观察组43例,男24例,女19例,年龄53~70岁,平均年龄(63.5±2.5)岁,病程6个月~3年,平均病程(1.8±0.5)年。两组患者一般资料对比,P>0.05,差异不具有统计学意义。
1.2方法
对照组采用常规治疗,给予华法林或阿司匹林抗凝,后依照患者情况及心率水平选取胺碘酮、β-受体阻滞剂、洋地黄类及钙离子拮抗剂等药物治疗。……
